Makary exit may temporarily lift biotech sentiment but FDA leadership vacuum looms
By Christy Santhosh May 13 (Reuters) - U.S. Food and Drug Administration Commissioner Dr. Marty Makary's departure comes as a positive move after a period of turmoil in the biotech sector, but until a permanent replacement is found, the industry could be under pressure, analysts and investors said. 
